Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet… Eikon Therapeutics (NAS: EIKN) is based in Millbrae, CA and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $972 million (Feb 2026). It has raised $1.5 billion.
Last price · $/share
—
Implied valuation
$971.7M
Total raised
$1.5B
Last round
—
Cap table — not yet on record
Eikon Therapeutics (NAS: EIKN)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
